The global response to AIDS is “under threat” because of an unprecedented backlash against human rights that is stigmatizing the groups most at risk of HIV infection, the head of the United Nations AIDS programme has warned.
It is possible to end AIDS by 2030 if countries demonstrate the political will to invest in prevention and treatment and adopt non-discriminatory laws, the United Nations said on Thursday.
China is not participating in a United Nations project to survey Asian wet markets and other facilities at high risk of spreading infectious diseases from wild animals to humans, despite long-running talks with Beijing, a UN official told Reuters.
India’s Hetero said on Tuesday that its generic version of Paxlovid, an antiviral treatment for COVID-19 developed by Pfizer Inc., was added to the World Health Organization’s prequalification list, which serves as a benchmark for procurement of medicines by developing countries.
To address its outsized environmental footprint, pharma is stepping up its initiatives to meet or exceed net zero standards for carbon emissions.
Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord reviewed by Reuters.
British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including sub-Saharan Africa where the virus remains a leading cause of death.
On Friday, the World Trade Organization approved vaccine patent waivers to increase the availability of COVID-19 vaccines to lower-income countries.
World Health Organization members formally agreed on Tuesday to a plan to overhaul its funding model which has been described as “fundamentally rotten” due to an over-reliance on the whims of donors.